Belinda Yeo Clinical Oncology Society of Australia Annual Scientific Meeting 2023

Abstracts this author is presenting:

• Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2− early breast cancer: primary results from the phase III NATALEE trial — Lunch, Poster Viewing, Exhibition & COSA Group Meetings